2026 GT Life Sciences & MedTech Investment and Partnership Symposium

Greenberg Traurig hosted its Life Sciences & MedTech Investment and Partnership Symposium during the J.P. Morgan Healthcare Conference in San Francisco, where industry leaders explored the most critical avenues for Asian life sciences and healthcare companies expanding into the U.S. market. This exclusive, in-person event delivered insights on 2025 deal activity and the outlook for 2026 across M&A, venture financing, and licensing transactions, while also examining how strategic intellectual property planning can drive valuations, attract investors and partners, and support long-term commercial success in the U.S. market. The program also addressed common challenges foreign biotech companies face when establishing a U.S. presence and shared practical guidance for mitigating risk, in addition to covering significant 2025 healthcare regulatory developments - including outbound investment, data transfer, the BIOSECURE Act, and AI-related regulations impacting cross-border transactions and product development in the life sciences and medical technology sectors.